Heterotopic ossification: pharmacologic options

J Head Trauma Rehabil. 2009 Jan-Feb;24(1):69-71. doi: 10.1097/HTR.0b013e31819a8fcc.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Bone Density Conservation Agents / therapeutic use
  • Brain Injuries / complications*
  • Dinoprostone / metabolism
  • Etidronic Acid / therapeutic use
  • Humans
  • Ossification, Heterotopic / complications*
  • Ossification, Heterotopic / drug therapy
  • Ossification, Heterotopic / epidemiology*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Bone Density Conservation Agents
  • Dinoprostone
  • Etidronic Acid